Purple Biotech Ltd
PPBT
$3.95
$0.102.55%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | 62.00K | 196.00K | |
| Gross Profit | -- | -- | -62.00K | -196.00K | |
| SG&A Expenses | -- | -- | 3.19M | 3.52M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 10.87M | 16.12M | |
| Operating Income | -- | -- | -10.87M | -16.12M | |
| Income Before Tax | -- | -- | -7.28M | -11.72M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -7.28 | -11.72 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | 39.00K | 65.00K | |
| Net Income | -- | -- | -7.24M | -11.66M | |
| EBIT | -- | -- | -10.87M | -16.12M | |
| EBITDA | -- | -- | -10.72M | -15.96M | |
| EPS Basic | -- | -- | -0.03 | -0.04 | |
| Normalized Basic EPS | -- | -- | -0.01 | -0.02 | |
| EPS Diluted | -- | -- | -0.03 | -0.04 | |
| Normalized Diluted EPS | -- | -- | -0.01 | -0.02 | |
| Average Basic Shares Outstanding | -- | -- | 1.30B | 1.15B | |
| Average Diluted Shares Outstanding | -- | -- | 1.30B | 1.15B | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |